Rein Therapeutics Inc. (RNTX:NASDAQ) closed at $0.552 on November 13, 2026, down 1.41% on the day. The stock trades 73.7% below its 52-week high of $2.10 and 10.2% above its 52-week low of $0.501. Over the past year, it lost 54.7%. Rein Therapeutics Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, RNTX closed higher on 109 days (43%). Its best day was October 27, 2026 (+20.75%) and its worst was May 1, 2026 (-23.99%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 1 time.
Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects.
Find more stocks like RNTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.